{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-Glutamate receptor (type NMDA) IFA"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K100017",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083850"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OSK"
    ],
    "Summary Letter Date": "August 4, 2010",
    "Summary Letter Received Date": "August 9, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple Autoantibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Autoantibodies against glutamate receptor (type NMDA)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Indirect immunofluorescent antibody assay",
        "TITERPLANE technology"
    ],
    "Methodologies": [
        "Indirect immunofluorescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-Glutamate receptor (type NMDA) IFA assay for detecting anti-NMDA receptor autoantibodies in human serum.",
    "Indications for Use Summary": "Qualitative determination of autoantibodies against glutamate receptor (type NMDA) in human serum, as an aid in diagnosis of anti-glutamate receptor (type NMDA) autoimmune encephalitis in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}